Clinical Trials · NCT07225686
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Amgen
- Enrollment
- 250
- Start date
- Dec 2025
- Locations
- 61 sites, 11 countries
- Primary endpoint
- Change in Apnea-Hypopnea Index (AHI) from baseline at week 52